Board Meeting6 Aug 2026, 05:50 pm
Gujarat Kidney to consider Q1 FY27 results on Aug 14, 2026
AI Summary
Gujarat Kidney and Super Speciality Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda for this meeting is to review and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. Concurrently, the company has implemented a trading window closure from June 1, 2026, until 48 hours after the announcement of these financial results, in compliance with SEBI's insider trading regulations.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- To consider unaudited financial results for Q1 FY27.
- Trading window closed from June 1, 2026.
- Closure is until 48 hours post-results announcement.
Price Impact
More from GKSL